clinical trial · NCT05645432
An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus
TinnitusBrexanolone
brief summary
The primary objective of this study is to evaluate the safety and tolerability of brexanolone in participants with tinnitus following a single 6-hour continuous intravenous (IV) infusion.
started
May 10, 2023
primary completion
Nov 21, 2023
completion
Nov 21, 2023
last updated
Sep 15, 2025
official title
An Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Brexanolone in the Treatment of Adult Participants With Tinnitus
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol